|4Feb 21, 4:00 PM ET

Dhanak Dashyant 4

4 · INCYTE CORP · Filed Feb 21, 2023

Insider Transaction Report

Form 4
Period: 2023-02-16
Dhanak Dashyant
EVP & Chief Scientific Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-02-16$65.42/sh+3,693$241,59656,956 total
  • Exercise/Conversion

    Incentive Stock Option (right to buy)

    2023-02-163,6930 total
    Exercise: $65.42Exp: 2028-12-10Common Stock (3,693 underlying)
Footnotes (2)
  • [F1]This includes an aggregate of 41,531 shares of common stock issuable pursuant to previously reported restricted stock units and earned performance shares that have not vested.
  • [F2]Beginning December 10, 2018, options become exercisable in 37 installments, with the first 25% vesting after one year and the remainder vesting monthly over three years.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION